EDWARD F MCCLAY M.D. NPI 1497727465

NPI Information

  • NPI: 1497727465
  • Provider Name: EDWARD F MCCLAY, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • Address: 838 NORDAHL RD STE 300
    SAN MARCOS, CA
    ZIP 92069
  • Phone: (760) 747-8935

Map and Directions

Get Directions

NPI Details

Edward F Mcclay, M.D. is a medical oncology internal medicine in San Marcos, CA. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Edward F Mcclay, M.D. NPI is 1497727465. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

838 NORDAHL RD STE 300
SAN MARCOS, CA
ZIP 92069-599
Phone: (760) 747-8935
Fax: (760) 466-0078

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Vitamin d-3 level (HCPCS:82306)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Unclassified drugs (HCPCS:J3490)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Electrophoresis, laboratory testing technique (HCPCS:82664)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Urinalysis, manual test (HCPCS:81002)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Folic acid level, serum (HCPCS:82746)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)

The enumeration date for this NPI number is 2/3/2006 and was last updated on 1/27/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyG64594CALIFORNIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.